Literature DB >> 7623392

Practice guidelines in the addictions. Recent developments.

R D Walker1, M O Howard, P S Walker, M D Lambert, R Suchinsky.   

Abstract

Consensually established principles of clinical conduct, known variously as practice guidelines, standards, protocols, or algorithms, have proliferated throughout medicine over the past decade. Institutional and disciplinary efforts to develop and promulgate guidelines for the treatment of additive disorders have recently been initiated. We review guideline development activities of the American Psychiatric Association, American Psychological Association, American Society of Addiction Medicine, American Nurses Association, National Association of Social Workers, and Center for Substance Abuse Treatment of the Substance Abuse and Mental Health Services Administration. Medical care performance and outcome assessments are discussed with attention to the role they can play in evaluating and refining guidelines. Potential effects of guidelines, salutary and deleterious, on clinical practice in the addictions are delineated.

Mesh:

Substances:

Year:  1995        PMID: 7623392     DOI: 10.1016/0740-5472(94)00079-7

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  3 in total

1.  A latent variable model of evidence-based quality improvement for substance abuse treatment.

Authors:  R D Lennox; A J Mansfield
Journal:  J Behav Health Serv Res       Date:  2001-05       Impact factor: 1.505

2.  Treatment guidelines for substance use disorders and serious mental illnesses: do they address co-occurring disorders?

Authors:  Brian E Perron; Alicia Bunger; Kimberly Bender; Michael G Vaughn; Matthew O Howard
Journal:  Subst Use Misuse       Date:  2010-06       Impact factor: 2.164

3.  Trends in acute mental health care: comparing psychiatric and substance abuse treatment programs.

Authors:  Christine Timko; Michelle Lesar; Noël J Calvi; Rudolf H Moos
Journal:  J Behav Health Serv Res       Date:  2003 Apr-Jun       Impact factor: 1.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.